Recombinant Human HMGB2/HMG-2 Protein，His

HMGB2 (High Mobility Group Box 2) is a non-histone chromosomal protein that plays a crucial role in various cellular processes, including transcription regulation, DNA repair, and chromatin remodeling. As a member of the high mobility group (HMG) protein family, HMGB2 is characterized by its ability to bind to DNA in a sequence-independent manner, facilitating the assembly of transcriptional machinery and enhancing gene expression. Research has demonstrated that HMGB2 is involved in numerous physiological and pathological contexts, including embryonic development, immune response, and cancer progression. Its expression levels are often dysregulated in various cancer types, making it a potential biomarker for tumorigenesis and a target for therapeutic interventions. The study of recombinant HMGB2 protein has become increasingly important in understanding its structural and functional dynamics, particularly in the context of DNA interactions. Methods to produce recombinant HMGB2, including expression systems such as E. coli or yeast, have enabled researchers to obtain purified protein necessary for in vitro assays and structural studies. These investigations aim to unveil the molecular mechanisms underlying HMGB2's role in chromatin architecture and its direct influence on gene regulation. Furthermore, characterizing the protein's binding affinity and specificity with different DNA structures can provide insights into its multifaceted functions in cellular processes. Overall, the research on recombinant HMGB2 is pivotal for elucidating its contribution to both normal cellular function and pathological conditions, ultimately guiding the development of novel therapeutic strategies targeting HMGB2-related pathways.